What does this research mean for the field?

Question

Accepted Answer

The long non-coding RNA Smyca forms a complex with FOXM1 to promote homologous recombination repair and immune evasion in triple-negative breast cancer, and its ablation sensitizes HR-proficient tumors to PARP inhibitors and chemotherapy. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

Smyca-FOXM1 ribonucleoprotein complex promotes homologous recombination and tumor immune evasion to define a therapeutic target of triple-negative breast cancer

Discussion

Member takes

Overview

Key Points

Cite This Study